Citations

Mayo Clinic

Showing 10 of 108572 citations.

Optimal Periprosthetic Tissue Specimen Number for Diagnosis of Prosthetic Joint Infection
Peel, Trisha , Dylla, Brenda L., Greenwood‐Quaintance, Kerryl E. , Cheng, Allen , Mandrekar, Jayawant N. , Patel, Robin , Peel, Trisha N, Hughes, John G, Spelman, Tim D. , Hughes, John , Patel, Robin

Journal of Clinical Microbiology | November 2, 2016 | Volume: 55 | Issue: 1 | Pages: 234-243

10.1128/jcm.01914-16 | PMID 27807152 Get It

ABSTRACT We recently demonstrated improved sensitivity of prosthetic joint infection (PJI) diagnosis using an automated blood culture bottle system for periprosthetic tissue culture [T. N. Peel et al., mBio 7(1):e01776-15, 2016, https://doi.org/10.1128/mBio.01776-15 ]. This study builds on the prior research by examining the optimal number of periprosthetic tissue specimens required for accurate PJI diagnosis. Current guidelines recommend five to six, which is impractical. We applied Bayesian latent class modeling techniques for estimating diagnostic test properties of conventional culture techniques (aerobic and anaerobic agars and thioglycolate broth) compared to inoculation into blood culture bottles. Conventional, frequentist receiver operating characteristic curve analysis was conducted as a sensitivity analysis. The study was conducted at Mayo Clinic, Rochester, MN, from August 2013 through April 2014 and included 499 consecutive patients undergoing revision arthroplasty from whom 1,437 periprosthetic tissue samples were collected and processed. For conventional periprosthetic tissue culture techniques, the greatest accuracy was observed when four specimens were obtained (91%; 95% credible interval, 77 to 100%), whereas when using inoculation of periprosthetic tissues into blood culture bottles, the greatest accuracy of diagnosis was observed when three specimens were cultured (92%; 95% credible intervals, 79 to 100%). Results of this study show that the greatest accuracy of PJI diagnosis is obtained when three periprosthetic tissue specimens are obtained and inoculated into blood culture bottles or four periprosthetic tissue specimens are obtained and cultured using standard plate and broth cultures. Increasing the number of specimens to five or more, per current recommendations, does not improve accuracy of PJI diagnosis.
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
Ahn, Daniel H. , Krishna, Kavya, Blazer, Marlo, Reardon, Joshua , Wei, Lai , Wu, Christina, Ciombor, Kristen K. , Noonan, Anne M. , Mikhail, Sameh , Bekaii‐Saab, Tanios , Wei, Lai , Noonan, Anne , Bekaii-Saab, Tanios S

Therapeutic Advances in Medical Oncology | November 2, 2016 | Volume: 9 | Issue: 2 | Pages: 75-82

10.1177/1758834016676011 | PMID 28203300 Get It

Background: Treatment with nab-paclitaxel with gemcitabine demonstrates a survival advantage when compared with single-agent gemcitabine. However, the combination is associated with significant toxicities, leading to a high rate of drug discontinuation. We implemented a modified regimen of gemcitabine and nab-paclitaxel (mGNabP) in an attempt to minimize toxicities while maintaining efficacy. Methods: A total of 79 evaluable patients with metastatic pancreatic adenocarcinoma (mPC) treated with a modified regimen of gemcitabine (1000 mg/m 2 ) and nab-paclitaxel (125 mg/m 2 ) on days 1, 15 of every 28-day cycle were identified from our prospective database. A total of 57 patients received this regimen as first-line treatment and were evaluated for toxicities, progression-free survival (PFS), and overall survival (OS). Overall, 22 patients with advanced or metastatic PC treated with the modified regimen outside the first-line setting were only evaluated for toxicities. Results: The median OS and PFS were 10 months [95% confidence interval (CI) 5.9–13 months] and 5.4 months (95% CI 4.1–7.4 months) for patients that received the modified regimen as first-line therapy. Neurotoxicity occurred in 27% with only 1.6% of patients experiencing grade ⩾3 toxicity. The incidence of grade ⩾3 neutropenia was 19%, resulting in growth factor support in 12% of patients. This rate was similar in patients who received the modified regimen for first-line treatment of mPC versus the overall group. Conclusions: A modified regimen of biweekly nab-paclitaxel with gemcitabine is associated with a lower cost, acceptable toxicity profile and appears to be relatively effective in pancreatic cancer. Prospective randomized studies confirming its potential benefits compared with standard weekly mGNabP are warranted.
Transplacental Passage of Acetaminophen in Term Pregnancy
Patil, Avinash S. , Langman, Loralie J., Penn, Hannah, Derleth, Douglas P., Watson, William J. , Nitsche, Joshua F. , Penn, Hannah J, Derleth, Douglas, Brost, Brian C, Brost, Brian

American Journal of Perinatology | November 2, 2016 | Volume: 34 | Issue: 06 | Pages: 541-543

10.1055/s-0036-1593845 | PMID 27806383 Get It

Antifibrinolytic therapy to reduce haemoptysis from any cause
Prutsky, Gabriela, Domecq, Juan Pablo , Salazar, Carlos A , Accinelli, Roberto A. , Domecq Graces, Juan Pablo

Cochrane Database of Systematic Reviews | November 2, 2016 | Volume: 2016 | Issue: 11 | Pages: No page available

10.1002/14651858.cd008711.pub3 | PMID 27806184 Get It

Immunosuppressive CD14 + HLA-DR lo/neg monocytes are elevated in pancreatic cancer and “primed” by tumor-derived exosomes
Javeed, Naureen , Gustafson, Michael P. , Dutta, Shamit K., Lin, Yi , Bamlet, William R. , Oberg, Ann L. , Petersen, Gloria M. , Chari, Suresh T. , Dietz, Allan B. , Mukhopadhyay, Debabrata , Dietz, Allan B , Bamlet, William R , Lin, Yi , Chari, Suresh T

OncoImmunology | November 2, 2016 | Volume: 6 | Issue: 1 | Pages: e1252013

10.1080/2162402x.2016.1252013 | PMID 28197368 Get It

Faculty Opinions recommendation of Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report.
Ryu, Jay H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726421746.793524896 Get It

Faculty Opinions recommendation of Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
Ryu, Jay H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726361294.793524894 Get It

Faculty Opinions recommendation of Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia.
Ryu, Jay H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726176054.793524891 Get It

Faculty Opinions recommendation of In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.
Ryu, Jay H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726000519.793524892 Get It

Faculty Opinions recommendation of Interstitial lung disease in connective tissue disease--mechanisms and management.
Ryu, Jay H.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718894725.793524890 Get It